These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System. Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353 [TBL] [Abstract][Full Text] [Related]
3. Modulatory Effects of Nicotine on neuroHIV/neuroAIDS. Han H; Yang Z; Chang SL; Li MD J Neuroimmune Pharmacol; 2018 Dec; 13(4):467-478. PubMed ID: 30215204 [TBL] [Abstract][Full Text] [Related]
4. Independent and Combined Effects of Nicotine or Chronic Tobacco Smoking and HIV on the Brain: A Review of Preclinical and Clinical Studies. Chang L; Liang H; Kandel SR; He JJ J Neuroimmune Pharmacol; 2020 Dec; 15(4):658-693. PubMed ID: 33108618 [TBL] [Abstract][Full Text] [Related]
5. The far-reaching HAND of cART: cART effects on astrocytes. Gonzalez H; Podany A; Al-Harthi L; Wallace J J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775 [TBL] [Abstract][Full Text] [Related]
6. Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research. Schnoll RA; Thompson M; Serrano K; Leone F; Metzger D; Frank I; Gross R; Mounzer K; Tyndale RF; Weisbrot J; Meline M; Collman RG; Ashare RL J Acquir Immune Defic Syndr; 2019 Feb; 80(2):e36-e40. PubMed ID: 30399039 [TBL] [Abstract][Full Text] [Related]
7. Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with HIV. Ruedisueli I; Shi K; Lopez S; Gornbein J; Middlekauff HR Physiol Rep; 2024 Jul; 12(14):e16158. PubMed ID: 39044007 [TBL] [Abstract][Full Text] [Related]
8. Rationale and design of a randomized factorial clinical trial of pharmacogenetic and adherence optimization strategies to promote tobacco cessation among persons with HIV. Quinn MH; Bauer AM; Fox EN; Hatzell J; Randle T; Purnell J; Rogers T; Stevens N; Leone F; Achenbach C; Wileyto EP; Josephson S; Gollan J; Ashare R; Hitsman B; Schnoll R; Gross R Contemp Clin Trials; 2021 Nov; 110():106410. PubMed ID: 33901574 [TBL] [Abstract][Full Text] [Related]
9. The effects of tobacco smoke and nicotine on cognition and the brain. Swan GE; Lessov-Schlaggar CN Neuropsychol Rev; 2007 Sep; 17(3):259-73. PubMed ID: 17690985 [TBL] [Abstract][Full Text] [Related]
10. Effects of cigarette smoking and nicotine dependence on adherence to antiretroviral therapy among HIV-positive patients in Vietnam. Nguyen NT; Tran BX; Hwang LY; Markham CM; Swartz MD; Vidrine JI; Phan HT; Latkin CA; Vidrine DJ AIDS Care; 2016; 28(3):359-64. PubMed ID: 26461976 [TBL] [Abstract][Full Text] [Related]
11. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221 [TBL] [Abstract][Full Text] [Related]
12. Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes. Ande A; McArthur C; Kumar A; Kumar S Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1453-64. PubMed ID: 23822755 [TBL] [Abstract][Full Text] [Related]
13. Differences in the rate of nicotine metabolism among smokers with and without HIV. Ashare RL; Thompson M; Leone F; Metzger D; Gross R; Mounzer K; Tyndale RF; Lerman C; Mahoney MC; Cinciripini P; George TP; Collman RG; Schnoll R AIDS; 2019 May; 33(6):1083-1088. PubMed ID: 30946162 [TBL] [Abstract][Full Text] [Related]
14. Recent Tobacco Smoking is Associated with Poor HIV Medical Outcomes Among HIV-Infected Individuals in New York. Hile SJ; Feldman MB; Alexy ER; Irvine MK AIDS Behav; 2016 Aug; 20(8):1722-9. PubMed ID: 26837623 [TBL] [Abstract][Full Text] [Related]
15. Tobacco use and nicotine dependence among people living with HIV who drink heavily in South Africa: a cross-sectional baseline study. Egbe CO; Londani M; Parry CDH; Myers B; Shuper PA; Nkosi S; Morojele NK BMC Public Health; 2019 Dec; 19(1):1684. PubMed ID: 31842834 [TBL] [Abstract][Full Text] [Related]
16. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy. Jaworowski A; Hearps AC; Angelovich TA; Hoy JF Front Immunol; 2019; 10():1378. PubMed ID: 31275317 [TBL] [Abstract][Full Text] [Related]
17. Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study. De Socio GV; Pasqualini M; Ricci E; Maggi P; Orofino G; Squillace N; Menzaghi B; Madeddu G; Taramasso L; Francisci D; Bonfanti P; Vichi F; dell'Omo M; Pieroni L; BMC Public Health; 2020 May; 20(1):734. PubMed ID: 32434482 [TBL] [Abstract][Full Text] [Related]
18. Associations Between Nicotine Metabolite Ratio and Gender With Transitions in Cigarette Smoking Status and E-Cigarette Use: Findings Across Waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Verplaetse TL; Peltier MR; Roberts W; Moore KE; Pittman BP; McKee SA Nicotine Tob Res; 2020 Jul; 22(8):1316-1321. PubMed ID: 32152625 [TBL] [Abstract][Full Text] [Related]
19. Brief Report: Nicotine Metabolism Ratio Increases in HIV-Positive Smokers on Effective Antiretroviral Therapy: A Cohort Study. Bien-Gund CH; Bilker W; Schnoll RA; Tyndale RF; Ho JI; Bremner R; Ashare RL; Gross R J Acquir Immune Defic Syndr; 2022 Apr; 89(4):428-432. PubMed ID: 34879005 [TBL] [Abstract][Full Text] [Related]
20. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury. Yuan NY; Kaul M J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]